Abstract
The discovery of a “specific soluble substance” secreted by pneumococci during growth (Dochez and Avery 1917) and the identification of this substance as a carbohydrate (Heidelberger and Avery 1923) were new and important developments in vaccine technology. This became evident when following the initial finding that the isolated capsular polysaccharides of pneumococci were immunogenic in mice (Schiemannand Casper 1927) it was demonstrated that they were also immunogenic in man (Francis and Tillet 1930). The potential of capsular polysaccharides as vaccines was fully confirmed when it was demonstrated unequivocally that multivalent pneumococcal polysaccharide vaccines were able to provide type-specific protection in humans against the acquisition of pneumococcal infection (MacLeod et al. 1945). However, at this time the phenomenal success of antibiotic therapy in the treatment of bacterial infections caused a lengthy hiatus in the further development of polysaccharide vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander HE, Heidelberger M, Leidy G (1944) The protective or curative element in type B H. influenzae rabbit serum. Yale J Biol. Med 16: 425–434
Anderson PW (1983) Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the non toxic protein CRM197. Infect Immun 39: 233–238
Anderson PW, Peter G, Johnston RB, Wetterlow LH, Smith DH (1972) Immunization of humans with polyribophosphate, the capsular antigen of Haemophilus influenzae type b. J Clin Invest 51: 39–44
Anderson PW, Pichichero ME, Insel R (1985) Immunization of two-month-old infants with protein- coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. J Pediatr 107:346–351
Anderson PW, Pichichero ME, Insel RA, Betts R, Eby R, Smith DH (1986) Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenza type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol 137:1181–1186
Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C (1970) Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 282: 417–420
Ashton FE, Ryan A, Diena B, Jennings HJ (1983) A new serogroup (L) of Neisseria meningitidis. J Clin Microbial 17: 722–727
Austrian R (1976) Vaccines of pneumococcal capsular polysaccharides and the prevention of pneumococcal pneumonia. In : Beers RF, Basset E (eds) The role of immunological factors in infectious, allergic, and autoimmune processes. Raven, New York, pp 79–89
Austrian R (1981) Some observations on the Pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis [Suppl] 3: S1–S17
Austrian R (1985) Polysaccharide vaccines. Ann Inst Pasteur Microbil 136B: 295–307
Avery OT, Goebel WF (1931) Chemo-immunological studies on conjugated carbohydrate proteins. V. Immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. J Exp Med 54: 437–447
Baker CJ, Edwards MS (1983) Group B streptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 2nd edn. Saunders, Philadelphia, pp 820–881
Baker CJ, Kasper DL (1985) Group B streptococcal vaccines. Rev Infect Dis 7: 458–467
Bax A, Egan W, Kovac P (1984) New NMR techniques for structure determination and resonance assignments of complex carbohydrates. J Carbohydr Chem 3: 593–611
Bax A, Summers MF, Egan W, Guirgis N, Schneerson R, Robbins JB, Ørskov F, et al. (1988) Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides. Carbohydr Res 173: 53–64
Beuvery EC, Kaaden A, Kunhai V, Leussink AB (1983 a) Physicochemical and immunochemical characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods. Vaccine 1: 31–36
Beuvery EC, Miedema F, van Delft R, Haverkamp J (1983b) Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines. Infect Immun 40: 39–45
Bhattacharjee AK, Jennings HJ, Kenny CP, Martin A, Smith ICP (1975) Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroup B and serogroup C with carbon 13 nuclear magnetic resonance. J Biol Chem 250: 1926–1932
Bhattacharjee AK, Jennings HJ, Martin A, Smith ICP (1976) Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135 and BO. Can J Biochem 54: 1–8
Bhattacharjee AK, Jennings HJ, Kenny CP (1978) Structural elucidation of the 3-deoxy-D-manno- octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance. Biochemistry 17: 645–651
Briles DE, Forman C, Hudak S, Claflin JL (1982) Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156: 1177–1185
Branefors-Helander P, Erbing C, Kenne L, Lindberg B (1976) Structural studies of the capsular antigen from Haemophilus influenzae type b. Acta Chem Scand [B] 30: 276–277
Bundle DR, Smith ICP, Jennings HJ (1974) Determination of the structure and conformation of bacterial polysaccharides by carbon-13 nuclear magnetic resonance. J Biol Chem 249: 2275–2281
Byrd RA, Egan W, Summers MF (1987) New NMR-spectroscopic approaches for structural studies of polysaccharides : application to the Haemophilus influenzae type a capsular polysaccharide. Carbohydr Res 166: 47–58
Cadoz M, Armand J, Arminjon F, Gire R, Lafaix C (1985) Tetravelent (Ak C, Y, W135) meningococcal vaccine in children : immunogenicity and safety. Vaccine 3: 340–342
Chu C, Schneerson R, Robbins JB, Rastogi SC (1983) Further studies on the immun enicity of Haemophilus influenzae type b and pneumoccocal type 6A polysaccharide-protein conjugates. Infect Immun 40: 245–256
Corfield AP, Schauer R (1982) Occurrence of sialic acids. In: Schauer R (ed) Sialic acids, chemistry, metabolism and function. Springer Berlin Heidelberg, New York, pp 5–50
Crisel RM, Baker RS, Dorman DE (1975) Capsular polymer of Haemophilus influenzae type b. Part 1. Structural characterization of the capsular polymer of strain Eagan. J Biol Chem 250 : 4926–4930
Ding S-Q, Ye R-B, Zhang H-C (1981) Three new serogroups of Neisseria meningitidis. J Biol Stand 9: 307–315
Dochez AR, Avery OT (1917) The elaboration of specific soluble substance by pneumococcus during growth. J Exp Med 26: 477–493
Douglas RM, Paton JC, Duncan SJ, Hansman DJ (1983) Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 148: 131–137
Edelman G (1983) Cell adhesion molecules. Science 219: 450–457
Egan W, Lui T-Y, Dorow D, Cohen JS, Robbins JD, Gotschlich EC, Robbins JB (1977) Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain BOS-12. Biochemistry 16: 3687–3692
Egan W, Schneerson R, Werner KE, Zon G (1982) Structural studies and chemistry of bacterial capsular polysaccharides. Investigations of phosphodiester-iinked capsular polysaccharides. Investigations of phosphodiester-iinked capsular polysaccharides isolated from Haemophilus influenzae types a, b, C and f: NMR spectroscopic identification and chemical modification of end groups and the nature of base catalyzed hydrolytic depolymerization. J Am Chem Soc 104: 2898–2910
Eskola J, Peltola H, Mäkelä PH, Käyhty H, Karanko V, Samuelson J, Gordon LK (1985) Antibody levels achieved in infants by course of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine. Lancet 1 (8439) : 1184–1186
Finland M (1979) Emergence of antibiotic resistance in hospitals, 1935–1975. Rev Infect Dis 1: 4–21
Finne J, Mäkelä PH (1985) Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. J Biol Chem 260: 1265–1270
Finne J, Finne V, Dlagostini-Bazin H, Goridis C (1983 a) Occurrence of α-2→8-linked polysialosyl units in a neural cell adhesion molecule. Biochim Biophys Res Commun 112: 482–487
Finne J, Leinonen M, Mäkelä PH (1983 b) Antigenic similarities between brain components and bacteria causing meningitis. Lancet 2(8346) : 355–357
Fischer GW, Lowell GM, Cumrine MH, Bass JW (1978) Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 anti- sera. J Exp Mrd 148: 776–786
Francis T Jr, Tillet WS (1930) Cutaneous reactions in pneumonia. The development of antibodies following intradermal injection of type specific polysaccharide. J Exp Med 52: 573–585
Frasch CE, Peppier MS (1982) Protection against group B Neisseria meningococcal disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect Immun 37: 271–280
Frosch M, Görgen I, Boulnois GJ, Timmis KN, Bitter-Suermann D (1985) NZB mouse system for production of monoclonal antibodies to weak bacterial antigens : isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli Kl and group B meningococci. Proc Natl Acad Sci USA 82: 1194–1198
Fry RM (1938) Fatal infections by haemolytic streptococcus group B. Lancet 1: 199–201
Glode MP, Lewin EB, Sutton A, Lee CT, Gotschlich EC, Robbins JB (1979) Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl negative variants and Escherichia coli K92 in adult volunteers. J Infect Dis 139: 52–59
Goebel WF (1940) Antibacterial immunity induced by artificial antigens. II. Immunity to experimental pneumococcal infection with antigens containing saccharides of synthetic origin. J Exp Med 72: 33–48
Goebel WF, Avery OT (1931) Chemo-immunological studies on conjugated carbohydrate proteins. IV. Synthesis of the p-aminobenzyl ether of the soluble specific substance of type III pneumococcus and its coupling with protein. J Exp Med 54: 431–436
Goldschneider I, Gotschlich EC, Artenstein MS (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1307–1326
Goldschneider I, Lepow ML, Gotschlich EC, Mauck FT, Bachl F, Randolph M (1973) Immunogenicity of the group A and group C meningococcal polysaccharides in human infants. J Infect Dis 128: 769–776
Gotschlich EC (1984) Meningococcal meningitis. In: Germanier E (ed) Bacterial vaccines. Academic, New York, pp 237–255
Gotschlich EC, Goldschneider I, Artenstein MS (1969 a) Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 129: 1367–1384
Gotschlich EC, Liu T-Y, Artenstein MS (1969b) Human immunity to meningococcus. 3. Preparation and immunochemical properties of the group A, group B and group C meningococcal polysaccharides. J Exp Med 129: 1349–1365
Gotschlich EC, Goldschneider I, Lepow ML, Gold R (1977) The immune responses to bacterial polysaccharides in man. In : Haber E, Krause RM (eds) Antibodies in human diagnosis and therapy. Raven, New York, pp 391–402
Gotschlich EC, Fraser BA, Nishimura O, Robbins JB, Liu T-Y (1981) Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem 256: 8915–8921
Heidelberger M, Avery OT (1923) Soluble specific substance of pneumococcus. J Exp Med 38: 73–79
Heidelberger M, Dilapi MM, Siegel M, Walter AW (1950) Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. J Immunol 65: 535–541
Howard JG, Christie GH, Courtenay BM, Leuchars E, Davies AJS (1971) Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to the type III pneumococcal polysaccharide. Cell Immunol 2: 614–626
James WM, Agnes WS (1987) Multiple oligosaccharide chains in the voltage-sensitive Na channel from Electrophorus electricus: Evidence for a α-2,8-linked polysialic acid. Biochem Biophys Res Commun 148: 817–826
Jansson PE, Lindberg B, Lindquist U (1981) Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 4. Carbohydr Res 95: 73–80
Jansson PE, Lindberg B, Lindquist U (1985) Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5. Carbohydr Res 140: 101–110
Jansson PE, Lindberg B, Lindquist U, Ljungberg J (1987) Structural studies of the capsular polysaccharide from Streptococcus pneumoniae types 15B and 15C. Carbohydr Res 162: 111–116
Jansson PE, Lindberg B, Anderson M, Lindquist U, Henrichsen J (1988) Structural studies of the capsular polysaccharide of Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr Res 182: 111–117
Jennings HJ (1983) Capsular polysaccharides as human vaccines. Adv Carbohydr Chem Biochem 41: 155–208
Jennings HJ (1985) Polysaccharides and conjugated polysaccharides as human vaccines. In: Crescenzi V, Dea ICM, Stivala SS (eds) New developments in industrial polysaccharides. Gordon and Breach, New York, pp 325–344
Jennings HJ, Lugowski C (1981) Immunochemistry of groups A, B and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol 127: 1011–1018
Jennings HJ, Lugowski C, Young NM (1980 a) Structure of the complex polysaccharide C-substance from Streptotoccuspneumoniae type 1. Biochemistry 19: 4712–4719
Jennings HJ, Rosell K-G, Carlo DJ (1980 b) Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 19 (19F). Can J Chem 58: 1069–1074
Jennings HJ, Lugowski C, Kasper DL (1981) Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry 20: 4511–4518
Jennings HJ, Rosell K-G, Kasper DL (1983 a) Structure of native polysaccharide antigens of types Ia and Ib group B Streptococcus. Biochemistry 22: 1258–1264
Jennings HJ, Rosell K-G, Katzenellenbogen E, Kasper DL (1983 b) Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J Biol Chem 258: 1793–1798
Jennings HJ, Katzenellenbogen E, Lugowski C, Michon F, Roy R, Kasper DL (1984) Structure, conformation and immunology of sialic acid containing polysaccharides of human pathogenic bacteria. Pure Appl Chem 56: 893–905
Jennings HJ, Roy R, Michon F (1985) Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis. J Immunol 134: 2651–2657
Jennings HJ, Roy R, Gamian A (1986) Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J Immunol 137: 1708–1713
Jennings HJ, Gamian A, Ashton FE (1987) N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J Exp Med 165: 1207–1211
Jones C, Mulloy B, Wilson A, Dell A, Oates JE (1985) Structure of the capsular polysaccharide from Streptococcus pneumoniae type 9. J Chem Soc Perkin Trans 1: 1665–1673
Jones JKN, Perry MB (1957) The structure of the type VIII pneumococcus specific polysaccharide. J Am Chem Soc 79: 2787–2793
Kabat EA (1966) The nature of an antigenic determinant. J. Immunol 97: 1–11
Kabat EA, Bezer AE (1958) The effect of variation in molecular weight on the antigenicity of dextran in man. Arch Biochem Biophys 78: 306–318
Kasper DL, Jennings HJ (1982) Immunological, immunochemical and structural studies of the type III and group B streptococcal polysaccharides. In: Easmon CSF, Jeljaszewicz J (eds) Medical microbiology, vol 1. Academic, New York, pp 183–216
Kasper DL, Baker CJ, Baltimore RS, Crabb JH, Schiffman G, Jennings HJ (1979) Immunodeterminant specificity of human immunity to type III group B Streptococcus. J Exp Med 149: 327–339
Katzenellenbogen E, Jennings HJ (1983) Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 19A(57). Carbohydr Res 124: 235–245
Käyhty H, Schneerson R, Sutton A (1983) Class-specific antibody response to Haemophilus influenza type b capsular polysaccharide vaccine. J Infect Dis 148: 767
Käyhty H, Karanko V, Peltola H, Mäkelä PH (1984) Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and response to reimmunization : no evidence of immunologic tolerance or memory. Pediatrics 74: 857–865
Kenne L, Lindberg B (1983) Bacterial polysaccharides. In: Aspinall GO (ed) The polysaccharides, vol 2. Academic, New York, pp 282–363
Kenne L, Lindberg B, Madden JK (1979) Structural studies on the capsular antigen from Streptococcus pneumoniae type 26. Carbohydr Res 73: 175–182
Lancefleld RC (1972) Cellular antigens of group B streptococci. In: Wannamaker LW, Matsen JM (eds) Streptococci and streptococcal diseases : recognition, understanding, and management. Academic, New York, pp 57–65
Lee C-J (1987) Bacterial capsular polysaccharides-biochemistry immunity and vaccine. Mol Immunol 24: 1005–1019
Leontein K, Lindberg B, Lönngren J (1981) Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 12F. Can J Chem 59: 2081–2085
Lerner L, Bax A (1987) Application of new, high sensitivity, 1H-13C-N.M.R.-spectral techniques to the study of oligosaccharides. Carbohydr Res 166: 35–46
Lifely MR, Gilbert AS, Moreno C (1981) Sialic acid polysaccharide antigens of Neisseria meningitidis and Escherichia coli : esteriflcation between adjacent residues. Carbohydr Res 94: 193–203
Lifely MR, Moreno C, Lindon JC (1987) An integrated molecular and immunological approach towards a meningococcal group B vaccine. Vaccine 5: 11–26
Lindberg B, Lönngren J, Powell DA (1977) Structural studies on the specific type 14 pneumococcal polysaccharide. Carbohydr Res 58: 177–186
Lindberg B, Lindqvist B, Lönngren J, Powell DA (1980) Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1. Carbohydr Res 78: 111–117
Lugowski C, Jennings HJ (1984) Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 18c (56). Carbohydr Res 131: 119–129
Lui T-Y, Gotschlich EC, Jonssen EK, Wysocki JR (1971 a) Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide. J Biol Chem 246: 2849–2858
Lui T-Y, Gotschlich EC, Dunne FT, Jonssen EK (1971 b) Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide. J Biol Chem 246 : 4703–4712
Lund E, Henrichsen J (1978) Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods Microbiol 12: 241–262
Lyles JM, Linnemann D, Bock E (1984) Biosynthesis of the D2-cell adhesion molecule : post-translational modifications, intracellular transport and developmental changes. J Cell Biol 99:2082–2091
MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG (1945) Prevention of pneumococcal pneumoniae by immunization with specific capsular polysaccharides. J Exp Med 82: 445–465
Mäkelä O, Peterfy F, Outschoorn IG, Richter AW, Séppala (1984) Immunogenic properties of alpha (1→6) dextran, its protein conjugates and conjugates of its breakdown products in mice. Scand J Immunol 19: 541–550
Mandrell RE, Zollinger WD (1982) Measurement of antibodies to meningococcal group B polysaccharide : Low avidity binding and equilibrium binding constants. J Immunol 129: 2172–2178
Marburg S, Jorn D, Tolman RL, Arison B, McCauley J, Kniskern PJ, Hagopian A, Vella PP (1986) Biomolecular chemistry of macromolecules : synthesis of bacterial polysaccharide conjugates with Neisseria meningitidis membrane protein. J Am Chem Soc 108: 5282–5287
Michon F, Brisson J-R, Roy R, Ashton FE, Jennings HJ (1985 a) Structural determination of the capsular polysaccharide of Neisseria meningitidis group I: A two-dimensional-NMR analysis. Biochemistry 24: 5592–5598
Michon F, Brisson J-R, Roy R, Ashton FE, Jennings HJ (1985 b) Structural determination of the group K capsular polysaccharide of Neisseria meningitidis: a 2D-NMR analysis. Can J Chem 63: 2781–2786
Michon F, Katzenellenbogen E, Kasper DL, Jennings HJ (1987 a) Structure of the complex group- specific polysaccharide of group B Streptococcus. Biochemistry 26: 476–486
Michon F, Brisson J-R, Jennings HJ (1987 b) Conformational differences between linear α(2 → 8)- linked homosialooligosaccharides and the epitope of the group B meningococcal polysaccharide. Biochemistry 26: 8399–8405
Michon F, Brisson J-R, Dell A, Kasper DL, Jennings HJ (1988) Multiantennary group-specific polysaccharide of group B Streptococcus. Biochemistry 27: 5341–5351
Moreau M, Richards JC, Perry MB, Kniskern PJ (1988) Application of high resolution nuclear magnetic resonance spectroscopy to the structural elucidation of the specific capsular polysaccharide of Streptococcus pneumoniae type 7F. Carbohydr Res 182: 79–99
Moreno C, Lifely MR, Esdaile J (1985 a) Immunity and protection of mice against Neisseria meningitidis group B by vaccination using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. Infect Immun 47: 527–533
Moreno C, Lifely MR, Esdaile J (1985 b) Effect of aluminium ions on chemical and immunological properties of meningococcal group B polysaccharide. Infect Immun 49: 587–592
Ohno N, Yadomae T, Miyazaki T (1980) The structure of the type-specific polysaccharide of Pneumococcus type XIX. Carbohydr Res 80: 297–304
Ørskov F, Orskov I, Sutton A, Schneerson R, Lin W, Egan W, Hoff GE, Robbins JB (1979) Form variation in Escherichia coli K1 : determined by O-acetylation of the capsular Dolysaccharide. J Exp Med 149: 669–685
Peltola H (1983) Meningococcal disease : still with us. Rev Infect Dis 5: 71–91
Peltola H, Käyhty H, Sivonen A, Mäkelä PH (1977) Haemophilus influenzae type b capsular polysaccharide vaccine in children : a double blind field study of 100,00 vaccines 3 months to 5 years of age in Finland. Pediatrics 60: 730–737
Perry MB, Daoust V, Carlo DJ (1981) The specific capsular polysaccharide of Streptococcus pneumoniae type 9V. Can J Biochem 59: 524–533
Perry MB, Bundle DR, Daoust V, Carlo DJ (1989) The structure of the specific polysaccharide of Streptococcus pneumoniae type 17F. Can J Biochem Cell Biol (in press)
Reberb PA, Heidelberger M (1961) The specific polysaccharide of type VI pneumococcus. II. The repeating unit. J Am Chem Soc 83: 3056–3059
Reeves RE, Goebel WF (1941) Chemoimmunological studies on the soluble specific substrate of pneumococcus. V. The structure of the type III polysaccharide. J Biol Chem 139: 511–519
Richards JC, Perry MB, Carlo DT (1983) The specific capsular polysaccharide of Streptococcus pneumoniae type 20. Can J Biochem Cell Biol 61: 178–190
Richards JC, Perry MB, Kniskem PJ (1981) The specific capsular polysaccharide of Streptococcus pneumoniae type 33F. Can J Biochem Cell Biol 62: 666–677
Richards JC, Perry MB (1988) Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F. Biochem Cell Biol 66: 758–771
Richards JC, Perry MB, Kniskem PJ (1989) Structural analysis of the specific capsular polysaccharide of Streptococcus pneumoniae type 22F. Can J Chem 67: 1038–1050
Richards JC, Perry MB, Moreau M (1988) Elucidation and comparison of the specific capsular polysaccharides of Streptococcus pneumoniae 11 (11F, 11B, 11C and 11A). Adv Exp Med Biol 228: 595–597
Richards JC, Perry MB (1989) Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 10A. Carbohydr Res (in press)
Rieger F, Grumet M, Edelman GM (1985) N-CAM at the vertebrate neuromuscular junction. J Cell Biol 101: 289–293
Robbins JB (1978) Vaccines for the prevention of encapsulated bacterial diseases : current status, problems and prospects for the future. Immunochemistry 15: 839–854
Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Makela PH, et al. (1983) Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148: 1136–1159
Roy R, Katzenellenbogen E, Jennings HJ (1984) Improved procedures for the conjugation of oligosaccharides to protein by reductive amination. Can J Biochen 62: 270–275
Rutishauser V, Watanabe M, Silver J, Troy FA, Vimr ER (1985) Specific alteration of NCAM- mediated cell adhesion by an endoneuroaminidase. J Cell Biol 101: 1842–1849
Sadler JE, Paulson JC, Hill RL (1979) The role of sialic acid in the expression of human MN blood group antigens. J Biol Chem 254: 2112–2119
Schiemann O, Casper W (1927) Sind die spezifisch pracipitablen Substanzen der 3 Pneumokokken-
Schiemann O, Casper W (1927) Sind die spezifisch pracipitablen Substanzen der 3 Pneumokokkentypen Haptene? Z Hyg Intektions Kr 108: 220–257
Schmidt MA, Jann K (1982) Phospholipid substitution of capsular (K) polysaccharide antigens from Escherichia coli causing extraintestinal infections. FEMS Microbiol Lett 14: 69–74
Schneerson R, Barrera O, Sutton A, Robbins JB (1980) Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 152: 361–376
Schwartz BA, Gray GR (1977) Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. Arch Biochem Biophys 181: 542–549
Sell SHW, Merrill RE, Doyne EO, Zimsky EP (1972) Long term sequelae of Haemophilus influenzae meningitis. Pediatrics 49: 206–211
Szu SC, Clark S, Robbins JB (1983) Protection against pneumococcal infection in mice conferred by phosphocholine binding antibodies. Specificity of the phosphocholine binding and relation to several types. Infect Immun 39: 993–999
Szu SC, Schneerson R, Robbins JB (1986 a) Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumo- cocci. Infect Immun 54: 448–455
Szu SC, Zon G, Schneerson R, Robbins JB (1986 b) Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. Carbohydr Res 155: 7–20
Tsui F-P, Egan W, Summers MF, Byrd RA (1988) Structure determination of the Escherichia coli K100 capsular polysaccharide cross-reactive with the capsular from type b Haemophilus influenzae. Carbohydr Res 173: 65–74
Wessels MR, Pozsgay V, Kasper DL, Jennings HJ (1987) Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. J Biol Chem 262: 8262–8267
Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL, Berman SL, Lowenthal JP (1972) Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 126: 514–521
Yount WJ, Dorner MM, Kunkel HG, Kabat EA (1968) Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med 127: 633–646
Zollinger WD, Mandrell RE, Griffis JM, Atieri P, Berman S (1979) Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J Clin Invest 63: 836–848
Zon G, Szu SC, Egan W, Robbins JD, Robbins JB (1982) Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides. Infect Immun 37: 89–103
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Jennings, H.J. (1990). Capsular Polysaccharides as Vaccine Candidates. In: Jann, K., Jann, B. (eds) Bacterial Capsules. Current Topics in Microbiology and Immunology, vol 150. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74694-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-74694-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74696-3
Online ISBN: 978-3-642-74694-9
eBook Packages: Springer Book Archive